Cite
HARVARD Citation
Mulligan, S. et al. (n.d.). Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia. Leukemia & lymphoma. 55 (12), pp. 2769-2777. [Online].